NO20075752L - Kimeriske proteiner, deres fremstilling og farmasoytiske sammensetninger som inneholder dem - Google Patents
Kimeriske proteiner, deres fremstilling og farmasoytiske sammensetninger som inneholder demInfo
- Publication number
- NO20075752L NO20075752L NO20075752A NO20075752A NO20075752L NO 20075752 L NO20075752 L NO 20075752L NO 20075752 A NO20075752 A NO 20075752A NO 20075752 A NO20075752 A NO 20075752A NO 20075752 L NO20075752 L NO 20075752L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- chimeric proteins
- chimeric protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL16795905 | 2005-04-11 | ||
PCT/IL2006/000456 WO2006109303A2 (fr) | 2005-04-11 | 2006-04-10 | Proteines chimeres et leur preparation, et compositions pharmaceutiques contenant lesdites proteines |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20075752L true NO20075752L (no) | 2008-01-11 |
Family
ID=36954510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20075752A NO20075752L (no) | 2005-04-11 | 2007-11-09 | Kimeriske proteiner, deres fremstilling og farmasoytiske sammensetninger som inneholder dem |
Country Status (9)
Country | Link |
---|---|
US (1) | US8092806B2 (fr) |
EP (1) | EP1871880B8 (fr) |
JP (1) | JP5122438B2 (fr) |
AU (1) | AU2006233929B2 (fr) |
CA (1) | CA2603779C (fr) |
ES (1) | ES2389527T3 (fr) |
IL (1) | IL186258A0 (fr) |
NO (1) | NO20075752L (fr) |
WO (1) | WO2006109303A2 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2642516T3 (es) * | 2007-09-04 | 2017-11-16 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Supresiones en el dominio II de la exotoxina A de Pseudomonas que reducen la toxicidad no específica |
US11246915B2 (en) | 2010-09-15 | 2022-02-15 | Applied Molecular Transport Inc. | Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo |
WO2012054693A1 (fr) * | 2010-10-22 | 2012-04-26 | Trudeau Institute | Utilisations du peptide yope de yersinia, gène, et sous-parties de celui-ci en tant que composant vaccinal contre la peste et dosage de lymphocytes t specifiques de yersinia pestis |
WO2013041247A1 (fr) * | 2011-09-23 | 2013-03-28 | Westfällsche Wilhelms-Universitaet Muenster | Protéine m externe de yersinia (yopm) dans le traitement du psoriasis induit par imiquimod |
EP2758068A1 (fr) * | 2011-09-23 | 2014-07-30 | Westfälische Wilhelms-Universität Münster | Protéine m externe de yersinia (yopm) dans le traitement du psoriasis |
AU2016227322A1 (en) * | 2015-03-03 | 2017-09-21 | Kahr Medical Ltd | Dual signaling protein (DSP) fusion proteins, and methods of using thereof for treating diseases |
CN105203766B (zh) * | 2015-09-29 | 2017-01-11 | 河南省科学院生物研究所有限责任公司 | 一种致病性小肠结肠炎耶尔森氏菌测试条制备方法 |
EP4316586A3 (fr) | 2018-03-08 | 2024-05-08 | Applied Molecular Transport Inc. | Constructions d'administration dérivées de toxines pour administration orale |
BR112021009001A8 (pt) | 2018-11-07 | 2021-10-26 | Applied Molecular Transport Inc | Veículos derivados de cholix para administração oral de carga útil heteróloga |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9702191D0 (sv) * | 1997-06-09 | 1997-06-09 | Sven Pettersson | Coposition and methods for the treatment of inflammatory dideases |
WO1999052563A1 (fr) * | 1998-04-16 | 1999-10-21 | The Regents Of The University Of California | Procede de ciblage de proteines produites par le yersinia dans le cytosol de cellules eukariotes |
GB0112687D0 (en) * | 2001-05-24 | 2001-07-18 | Microbiological Res Authority | Pharmaceutical use of secreted bacterial effector proteins |
-
2006
- 2006-04-10 US US11/911,252 patent/US8092806B2/en not_active Expired - Fee Related
- 2006-04-10 JP JP2008506052A patent/JP5122438B2/ja not_active Expired - Fee Related
- 2006-04-10 AU AU2006233929A patent/AU2006233929B2/en not_active Ceased
- 2006-04-10 EP EP06728257A patent/EP1871880B8/fr active Active
- 2006-04-10 ES ES06728257T patent/ES2389527T3/es active Active
- 2006-04-10 CA CA2603779A patent/CA2603779C/fr not_active Expired - Fee Related
- 2006-04-10 WO PCT/IL2006/000456 patent/WO2006109303A2/fr active Application Filing
-
2007
- 2007-09-25 IL IL186258A patent/IL186258A0/en unknown
- 2007-11-09 NO NO20075752A patent/NO20075752L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2006109303A3 (fr) | 2006-12-07 |
CA2603779C (fr) | 2015-05-19 |
EP1871880B1 (fr) | 2012-08-08 |
EP1871880B8 (fr) | 2012-09-12 |
IL186258A0 (en) | 2008-01-20 |
JP5122438B2 (ja) | 2013-01-16 |
US8092806B2 (en) | 2012-01-10 |
CA2603779A1 (fr) | 2006-10-19 |
ES2389527T3 (es) | 2012-10-29 |
AU2006233929A1 (en) | 2006-10-19 |
EP1871880A2 (fr) | 2008-01-02 |
US20080287356A1 (en) | 2008-11-20 |
JP2008535514A (ja) | 2008-09-04 |
WO2006109303A2 (fr) | 2006-10-19 |
AU2006233929B2 (en) | 2012-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20075752L (no) | Kimeriske proteiner, deres fremstilling og farmasoytiske sammensetninger som inneholder dem | |
NO20062709L (no) | Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller | |
NO20075693L (no) | Modulerende forbindelser av indolamin-2,3-dioksygenase og fremgangsmater for anvendelse av samme | |
EA200802170A1 (ru) | Лиофилизированная композиция терапевтического пептидного антитела | |
MY151036A (en) | Synthesis of (r)-n-methylnaltrexone | |
NO20091413L (no) | WNT-antagonister og deres anvendelse i diagnostiseringen og behandlingen av WNT-medierte forstyrrelser | |
CY1118065T1 (el) | Καινοτομες αμινογλυκοσιδες και χρησεις αυτων στη θεραπεια γενετικων διαταραχων | |
NO20044618L (no) | Dedifferensierte, programmerbare stamceller av monocyttisk opprinnelse og deres fremstilling og anvendelse | |
NO20064584L (no) | Tetrahydropyridoindolderivater | |
EA200870599A1 (ru) | Стабильные препараты лаквинимода | |
EA201000399A1 (ru) | Композиции и способы использования проостровковых пептидов и их аналогов | |
BRPI0610108B8 (pt) | compostos promotores de apoptose e composição que compreende os ditos compostos | |
NO20064347L (no) | Substituerte 1,2,3,4-tetrahydroisokinolinderivater | |
GEP20084452B (en) | Sulfonamide derivatives for the treatment of diseases | |
NO20090628L (no) | Pyridizinon derivativater | |
BRPI0418251C1 (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo | |
MX2020006822A (es) | Proteinas de fusion de anticuerpo de un solo dominio-citosina desaminasa. | |
NO20090305L (no) | Cyklosporin formuleringer | |
NO20080745L (no) | Nye peptider for anvendelse i behandling av fedme | |
SE0301653D0 (sv) | Novel compounds | |
NO20070487L (no) | 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer. | |
IL171914A0 (en) | Variants of il-18bp, their preparation and pharmaceutical compositions containing them | |
NO20050932L (no) | 1-pyridin-4-yl-ureaderivater | |
NO341679B1 (no) | Substituerte pyridylamidforbindelser, fremstilling av slike og farmasøytiske sammensetninger inneholdende slike, samt anvendelse som modulatorer av histamin H3-reseptoren | |
NO20073059L (no) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |